课题基金 / 基金详情

Mechanisms involved in loss of PI-anchored proteins (DAF and CD59) in human leukemia cell lines.

Mechanisms involved in loss of PI-anchored proteins (DAF and CD59) in human leukemia cell lines.
人类白血病细胞系中 PI 锚定蛋白(DAF 和 CD59)丢失的机制。
批准号:
05671933
负责人:
HATANAKA Michiyo
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1995

项目摘要

项目成果

HATANAKA Michiyo的其他基金

相关文献

中文摘要
翻译
我们研究了糖基磷脂酰肌醇(GPI)锚定的补体调节蛋白DAF和/或CD59在一组缺乏表面表达的人白血病细胞系U937(DAF^/CD59^-)、CEM(DAF^<-E1S1>)、Tall(DAF^-/CD59^-)和Ramos的a亚株[Ramos(-)](DAF^-/CD59^-),Northe印迹和逆转录聚合酶链式反应(RT-PCR)表明,DAF和/或CD59缺失的主要原因是除Ramos(-)外的大多数细胞株都没有表达足够的DAF和CD59的mRNA,从其他GPI锚定蛋白的检测来看,U937、CEM和TALL细胞在GPI锚定形成方面没有缺陷。Southern blotting未检测到与DAF或CD59对应的基因异常。因此,除Ramos(-)外,这些白血病细胞系中DAF和/CD59缺陷的原因是几乎无法检测到相关mRNA的稳态水平,很可能是由于这些细胞系中转录步骤的异常所致。另一方面,Ramos(-)细胞不能产生GPI锚,而它正常表达DAF和CD59转录本。将PIGA基因导入Ramos(-)细胞,恢复了DAF和CD59的表达,表明GPI锚点形成缺陷的机制类似于阵发性睡眠性血红蛋白尿(PNH)细胞,PNH是PIG-A基因产物的缺失。因此,人类白血病细胞株中DAF和/或CD59缺陷的机制并不统一,与已提出的引起PNH的机制大部分不同。
英文摘要
We investigated the mechanisms of defects of glycosyl-phosphatidylinositol (GPI) -anchored complement regulatory proteins, DAF and/or CD59, in a panel of human leukemia cell lines that lack surface expression of these proteins : U937 (DAF^+/CD59^-), CEM (DAF^<-E1S1+>), TALL (DAF^-/CD59^-), and a substrains of Ramos [Ramos (-)] (DAF^-/CD59^-), Northe blot and reverse transcriptase-polymerase chain reaction (RT-PCR) revealed that the main cause of the DAF and/or CD59 deficiency is the failure of mRNA expression in most of the cell lines except for Ramos (-) which allowed the generation of the sufficient mRNA of DAF and CD59 U937, CEM,and TALL cells were not defective in GPI anchor formation as assesse by the detection of other GPI-anchored proteins. No gene abnormality corresponding to DAF or CD59 was detected by Southern blotting. Thus, the cause of the defects of DAF and/CD59 in these leukemia cell lines except for Ramos (-) is virtually undetectable steady state levels of the relevant mRNA,most likely, is attributable to aberrance at the transcription steps in these cell lines. On the other hand, Ramos (-) cells failed to generate a GPI anchor, whereas it normally expressed DAF and CD59 transcripts. The transfection of PIGA cDNA to Ramos (-) cells restored the DAF and CD59 expression, indicating that the mechanism defective in GPI-anchor formation is similar to that of paroxysmal nocturnal hemoglobinuria (PNH) cells, a deficiency of the PIG-A gene product. Thus, the mechanisms of the defects of DAF and/or CD59 in human leukemia cell lines are not uniform and are mostly different from that proposed to cause PNH.
期刊论文(44)
专著(0)
科研奖励(0)
会议论文
畑中 道代: "Mechanisms by which the surface-expression of GPI-ancbored complement regulatory proteins, DAF and CD59, are lost in human leukemia cell lines" Biochem. J.314. 969-976 (1996)
Michiyo Hatanaka:“人白血病细胞系中 GPI 锚定的补体调节蛋白 DAF 和 CD59 的表面表达丢失的机制”Biochem J.314 (1996)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
瀬谷 司: "Acute promyelocytic leukemia with CD59 deficiency" Leukemia Research. 17. 895-896 (1993)
Tsukasa Seya:“CD59 缺乏的急性早幼粒细胞白血病”《白血病研究》17. 895-896 (1993)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
宮川 周士: "Possibility for prevention of hyperacute rejection of DAF and CD59 in xenotransplantation." Transplant Proc.26. 1235-1238 (1994)
Shuji Miyakawa:“异种移植中预防 DAF 和 CD59 超急性排斥反应的可能性”,Proc.26(1994)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
28
    Mechanisms involved in GPI-anchored-protein signaling dimer formation
    • 批准号:
      10672190
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.11万
    • 财政年份:
      1998
    • 负责人:
      HATANAKA Michiyo
    • 依托单位:
    The Signal Transduction Mechanisms of a GPI-anchored Complement Regulatory Protein, CD59.
    • 批准号:
      08672654
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.47万
    • 财政年份:
      1996
    • 负责人:
      HATANAKA Michiyo
    • 依托单位:
    Studies on the mechanisms of C9 activation and of C9 inactivation by the regulatory protein(MACIF)
    • 批准号:
      03671118
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1991
    • 负责人:
      HATANAKA Michiyo
    • 依托单位: